Find a Doctor or Practice Location

You can also search for providers and practices at Penn Medicine Lancaster General Health or Princeton Health.

I am searching for a
Reset Form
Lawrence N. Shulman, MD

Lawrence N. Shulman, MD Physician

Deputy Director, Clinical Services, Abramson Cancer Center Director, Center for Global Cancer Medicine, Abramson Cancer Center Professor of Medicine at the Hospital of the University of Pennsylvania

Dr. Shulman is employed by Penn Medicine.

Does not see patients

No Patient Satisfaction Reviews
Why not?

There is no publicly available rating for this medical professional for one of the following reasons:

  1. He or she is not employed by Penn Medicine.
  2. He or she does not see patients in a medical practice setting.
  3. He or she sees patients but has not yet received the minimum 30 patient satisfaction reviews in the past 12 months, ensuring that the rating is statistically reliable and a true reflection of patient satisfaction.

Clinical Specialties


  • Medical Oncology

Programs & Centers:

Board Certification:

  • Hematology, 1982
  • Internal Medicine, 1978
  • Medical Oncology, 1981

Clinical Expertise:

  • Adjuvant Chemotherapy
  • Aromatase Inhibitor
  • Atypical Ductal Hyperplasia
  • BRCA
  • Breast Cancer
  • Breast Cancer Chemotherapy
  • Breast Cancer During Pregnancy
  • Breast Cancer Follow Up
  • Breast Cancer Genetics
  • Breast Cancer High-Risk Counseling
  • Carcinoma In Situ of Breast
  • Cystosarcoma Phyllodes
  • ER Negative Breast Cancer
  • ER Positive Breast Cancer
  • Family History of Breast Cancer
  • Herceptin
  • Hereditary Breast and Ovarian Cancer
  • Immunotherapy
  • Inflammatory Breast Cancer (IBC)
  • Invasive Breast Cancer
  • Lobular Neoplasia
  • Male Breast Cancer
  • Neoadjuvant Chemotherapy
  • Sentinel Lymph Node Biopsy
  • Tamoxifen
  • Triple-Negative Breast Cancer
Show All Expertise

Insurance Accepted

  • Aetna US Healthcare
  • Amerihealth Caritas
  • Amerihealth Caritas Medicare
  • Cigna
  • Cigna HealthSpring
  • Clover Health Plan
  • CVS Health
  • Devon Health Services (Americare)
  • eLAP Services
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthPartners Medicare
  • HealthSmart
  • Highmark Blue Shield
  • Homestead Smart Health Plans
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Keystone First Medicare
  • Multiplan
  • NJ Medicaid
  • NJ Qualcare
  • OPR Medicare
  • OPR New Jersey Medicaid
  • OPR Pennsylvania Medicaid
  • Oscar Health Plan of PA
  • Oxford Health Plan
  • PA Health and Wellness (Centene) Medicare
  • PA Medicaid
  • PA Medicare
  • Preferred Health Care/LGH
  • Provider Partners Health Plan
  • Rail Road Medicare / Palmetto GBA
  • Remedy Partners at Penn Medicine
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan
  • Veterans Choice Program

Education and Training

Medical School: Harvard Medical School
Residency: Beth Israel Deaconess Medical Center
Fellowship: Beth Israel Deaconess Medical Center


American College of Physicians, National American College of Surgeons, Commission on Cancer, Representative from the American Society of Clinical Oncology, National American Society of Clinical Oncology, National American Society of Hematology, National ASAN Institute for Life Sciences, Seoul, Korea, International ASCP Partners for Cancer Diagnosis and Treatment Initiative Advisory Committee, National Breast Health Global Initiative, Steering Committee, International Davidoff Cancer Center, Rabin Medical Center, Tel Aviv, Israel, International Global Oncology, International National Cancer Policy Forum, National NCCN Best Committee, National Partners In Health, International The Max Foundation, National University of Global Health Equity, Rwanda, International World Health Organization, International

Hospital Affiliation

Dr. Shulman is employed by Penn Medicine.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.


Selected Publications:

Butonzi J, Forbes V, Kigonya C, Lansigan F, Davis T, Figueroa K, Ruhangaza D, Shabani K, Nininahazwe P, Nkunsi E, Habimana O, Haley J, Buswell L, Costa C, Hill A, Sharma P, Hanna C, Fehr A, DeBoer B, Park P, Sebahungu F, Mpanumusingo E, Shyirambere C, Mpunga T, Shulman LN, Chamberlin M: Global oncology fellowship electives: The impact on cancer care and international collaborations Rwanda Med J : 2019, in press.

Vapiwala N, Thomas CR, Grover S, Yap ML, Mitin T, Shulman LN, Gospodarowicz MK, Longo J, Petereit DG, Ennis RD, Hayman JA, Rodin D, Buchsbaum JC, Vikram B, Abdel-Wahab M, Epstein AH, Okunieff P, Goldwein J, Kupelian P, Weidhaas JB, Tucker MA, Boice JD, Fuller CD, Thompson RF, Trister AD, Formenti SC, Barcellos-Hoff MH, Jones J, Dharmarajan KV, Zietman AL, Coleman CN: Enhancing career paths for tomorrow’s radiation oncologists Int J Radiat Oncol Biol Phys : 2019.

Kline RM, Rocque GB, Rohan EA, Blackley KA, Cantril CA, Pratt-Chapman ML, Burris HA, Shulman LN: Patient navigation in cancer: The business case to support clinical needs J Oncol Prac : 2019.

Schleimer LE, Dusengimana JMV, Butonzi J, Kigonya C, Natarajan A, Umwizerwa A, O’Neil DS, Costas-Chavarri A, Majyambere JP, Shulman LN, Keating NL, Shyirambere C, Mpunga T, Pace LE: Barriers to timely surgery for breast cancer in Rwanda J Surg : 2019.

Pomponio MK, Keele LJ, Fox KR, Clark AS, Matro JM, Shulman LN, Tchou JC: Does time to adjuvant chemotherapy (TTC) affect outcomes in patients with triple-negative breast cancer? Breast Cancer Res Treat : 2019.

Shulman LN, Browner AE, Palis BE, Mallin K, Kakade S, Carp N, McCabe R, Winchester D, Wong SL, McKellar DP: Compliance with cancer quality measures over time and their association with survival outcomes: The Commission on Cancer’s experience with the quality measure requiring at least 12 regional lymph nodes are removed with colon cancer resections Ann Surg Oncol : 2019.

Dao D, Zemla T, Jatoi A, Freedman RA, Hurria A, Muss H, Cohen HJ, Shulman LN, Citron M, Budman D, McMurray R, Partridge A, Carey L, Sedrak MS, Lafky JM, Le-Rademacher JG: Older-patient-specific cancer trials: A pooled analysis of 2,277 patients (A151715) Oncologist 24 : e284-e291,2019.

Lopez D, Pratt-Chapman ML, Rohan EA, Sheldon LK, Basen-Engquist K, Kline R, Shulman LN, Flores EJ: Establishing effective patient navigation programs in oncology Support Care Cancer 27 (6): 1985-1996,2019.

Mehta S, Weber K, Fleisher L, Shulman LN, Gabriel P, Trerotola SO, Nawas M, Chi AS, Sebro R: Assessing the need for preprocedural laboratory tests and stopping non-steroidal anti-inflammatory drugs/aspirin in patients undergoing percutaneous bone and soft tissue biopsies Cardiovasc Intervent Radiol : 2019.

Nekhlyudov L, Mollica MA, Jacobsen P, Mayer DK, Shulman LN, Geiger AM: Developing a quality of cancer survivorship care framework: Implications for clinical care, research, and policy J Natl Cancer Inst : 2019.

Academic Contact Info

Abramson Cancer Center
3400 Civic Center Boulevard
Perelman Center for Advanced Medicine
South Pavilion, 12-111

Philadelphia, PA 19104